Markstone Fund raises $800m.

Until now, Markstone has raised approximately $700m. in funds earmarked for investments in Israel.

October 8, 2005 17:09
1 minute read.


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Markstone Capital Partners Fund has raised $800 million in investment capital, a spokesperson for the fledgling investment fund said Sunday. The total is some $300m. more than than the fund originally intended to raise and included investors from both the US and Israel. The spokesperson said that the funding took approximately two years complete, but would not disclose who the main investors were. The fund is run in Israel by its two managing directors and cofounders Ron Lubash and Amir Kess, and in the US by cofounder Elliot Broidy who serves as its chairman. Until now, Markstone has raised approximately $700m. in funds earmarked for investments in Israel. Its portfolio of investments include its acquisition of a controlling stake of phone directory company Golden Pages for NIS 500m. made in October 2004 as its first investment. Subsequent deals include its purchase of 40% of engineering company PRS Mediterranean for $100m. and 20% of textile company Nilit. It is currently in legal proceedings with Japanese seed producer Sakata for the purchase of Zeraim Gadera. The company's advisory board includes United Mizrahi Bank CEO Ya'acov Perry, former finance minister Ya'acov Neeman, Teva Pharmaceuticals CEO Eli Hurvitz, Lehman Brothers vice-chairman Harvey Krueger, and Home Depot founder Kenneth Langone.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection